Drugs Online |
 |
 | ||
|
Janumet Generic Metformin |
|
| ||
Drugs Online » Prescription Drugs 9 » Janumet Generic Metformin Janumet is an oral diabetes medicines that help control blood sugar levels.Metformin works by decreasing glucose (sugar) production in the liver and decreasing absorption of glucose by the intestines.Sitagliptin works by regulating the levels of insulin your body produces after eating.Janumet is for people with type 2 diabetes who do not use daily insulin injections. It is used along with diet and exercise. Janumet is not for treating type 1 diabetes. Buy Janumet Generic Metformin and other Prescription Drugs 9 products online at Medstore. Buy Online at Medstore - Click Here!
About Janumet Generic Metformin: Product Type: Prescription Drugs 9 Janumet (Generic Metformin/Sitagliptin) Janumet (Generic Metformin/Sitagliptin) Generic Metformin/Sitagliptin 1000/50mg 14 Tablets 3 x 14 Tablets 6 x 14 Tablets Generic Metformin/Sitagliptin Janumet
View more Prescription Drugs 9 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
